← SynDRA
RO-5045337
SynDRA canonical compound SYN0037354 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | MDM2 |
| Mechanism of action | mdm inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- MDM2 ANTAGONIST RO5045337
- R-7112
- RG-7112
- RG7112
- RO5045337
- UNII-Q8MI0X869M
- QBGKPEROWUKSBK-QPPIDDCLSA-N
- Q8MI0X869M
- Ro 5045337
- CHEMBL2386346
- GTPL9599
- SCHEMBL12704861
- DTXSID60240182
- MolPort-044-560-282
- EX-A1686
- s7030
- ZINC96270381
- BDBM50434287
- AKOS027282701
- CS-0330
- HY-10959
- RG7112 (RO5045337)
- [(4s,5r)-2-(4-t-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethylimidazol-1-yl]-[4-(3-methylsulfonylpropyl)piperazin-1-yl]methanone
- Methanone, [(4S,5R)-4,5-bis(4-chlorophenyl)-2-[4-(1,1-dimethylethyl)-2-ethoxyphenyl]
- RG 7112
- Mdm2 antagonist ro5045337
- R 7112
- RefChem:179699
- DTXCID60162673
- R7112
- C38H48Cl2N4O4S
- MFCD29905459
- SCHEMBL29508998
- GLXC-90449
- R 7112 [WHO-DD]
- MFCD18206914
- NSC809100
- CCG-270414
- EBC-415041
Look up RO-5045337 in the interactive SynDRA portal →